Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2023/02/02
-
Journal
-
Indian UGC (journal)
-
Refrences10
-
Citations5
-
Marcello D’Amelio Department of Medicine and Surgery, Università Campus Bio-Medico di Roma , 00128 Rome , ItalyDepartment of Experimental Neurosciences, IRCCS Santa Lucia Foundation , 00143 Rome , Italy
-
Vincenzo Di Lazzaro Department of Medicine and Surgery, Università Campus Bio-Medico di Roma , 00128 Rome , ItalyOperative Research Unit of Neurology, Fondazione Policlinico Universitario Campus Bio-Medico , 00128 Rome , Italy
Cite
D’Amelio, Marcello, and Vincenzo Di Lazzaro. “Can Transcranial Magnetic Stimulation Rescue Dopaminergic Signalling in Alzheimer’s Disease?”. Brain, vol. 146, no. 6, 2023, pp. e43-e45, https://doi.org/10.1093/brain/awad019.
D’Amelio, M., & Di Lazzaro, V. (2023). Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer’s disease?. Brain, 146(6), e43-e45. https://doi.org/10.1093/brain/awad019
D’Amelio M, Di Lazzaro V. Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer’s disease?. Brain. 2023;146(6):e43-e45.
Journal Categories
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Neurology
Diseases of the nervous system
You May Also Like
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
- Staging of alzheimer's disease-related neurofibrillary changes
- When does age-related cognitive decline begin?
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Precuneus magnetic stimulation for Alzheimer’s disease: a randomized, sham-controlled trial | Brain |
| 53 | 2022 |
| Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia | Clinical Neurophysiology |
| 84 | 2021 |
| Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to Alzheimer’s disease: Implications for treatment | 2021 | |||
| Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions | Neurotherapeutics | 10 | 2021 | |
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases | Alzheimer's Research & Therapy |
| 26 | 2021 |
Refrences Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 7
is the most frequently represented among the references in this article. It primarily includes studies from Translational Neurodegeneration and Nature Communications. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Emerging trends on nanomaterial-based simultaneous electrochemical sensing of dopamine and acetaminophen | Results in Chemistry |
| 2024 | |
| Designed Directional Growth of Ti-Metal–Organic Frameworks for Decoding Alzheimer’s Disease-Specific Exosome Metabolites | Analytical Chemistry |
| 2024 | |
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease | Molecular Psychiatry |
| 5 | 2024 |
| The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases | Ageing Research Reviews |
| 15 | 2023 |
| Reply: Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer’s disease? | Brain |
| 2023 |
Citations Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 2
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases and was published in 2023. The most recent citation comes from a 2024 study titled Emerging trends on nanomaterial-based simultaneous electrochemical sensing of dopamine and acetaminophen. This article reached its peak citation in 2024, with 3 citations. It has been cited in 5 different journals. Among related journals, the Results in Chemistry cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.